{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,21]],"date-time":"2026-11-21T18:12:06Z","timestamp":1795284726281,"version":"4.10.3"},"reference-count":85,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2023,1,9]],"date-time":"2023-01-09T00:00:00Z","timestamp":1673222400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,1,9]],"date-time":"2023-01-09T00:00:00Z","timestamp":1673222400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/100007219","name":"Natural Science Foundation of Shanghai","doi-asserted-by":"publisher","award":["22ZR1415000"],"award-info":[{"award-number":["22ZR1415000"]}],"id":[{"id":"10.13039\/100007219","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000049","name":"U.S. Department of Health & Human Services | NIH | National Institute on Aging","doi-asserted-by":"publisher","award":["RF1 AG061874"],"award-info":[{"award-number":["RF1 AG061874"]}],"id":[{"id":"10.13039\/100000049","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000049","name":"U.S. Department of Health & Human Services | NIH | National Institute on Aging","doi-asserted-by":"publisher","award":["P01 AG002132"],"award-info":[{"award-number":["P01 AG002132"]}],"id":[{"id":"10.13039\/100000049","id-type":"DOI","asserted-by":"publisher"}]},{"name":"U.S. Department of Health & Human Services | NIH | National Institute on Aging"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Commun"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Microglia are central to pathogenesis in many neurological conditions. Drugs targeting colony-stimulating factor-1 receptor (CSF1R) to block microglial proliferation in preclinical disease models have shown mixed outcomes, thus the therapeutic potential of this approach remains unclear. Here, we show that CSF1R inhibitors given by multiple dosing paradigms in the Tg2541 tauopathy mouse model cause a sex-independent reduction in pathogenic tau and reversion of non-microglial gene expression patterns toward a normal wild type signature. Despite greater drug exposure in male mice, only female mice have functional rescue and extended survival. A dose-dependent upregulation of immediate early genes and neurotransmitter dysregulation are observed in the brains of male mice only, indicating that excitotoxicity may preclude functional benefits. Drug-resilient microglia in male mice exhibit morphological and gene expression patterns consistent with increased neuroinflammatory signaling, suggesting a mechanistic basis for sex-specific excitotoxicity. Complete microglial ablation is neither required nor desirable for neuroprotection and therapeutics targeting microglia must consider sex-dependent effects.<\/jats:p>","DOI":"10.1038\/s41467-022-35753-w","type":"journal-article","created":{"date-parts":[[2023,1,9]],"date-time":"2023-01-09T09:15:18Z","timestamp":1673255718000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":48,"title":["CSF1R inhibitors induce a sex-specific resilient microglial phenotype and functional rescue in a tauopathy mouse model"],"prefix":"10.1038","volume":"14","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-0969-0066","authenticated-orcid":false,"given":"Noah R.","family":"Johnson","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4051-4447","authenticated-orcid":false,"given":"Peng","family":"Yuan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2492-901X","authenticated-orcid":false,"given":"Erika","family":"Castillo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"T. Peter","family":"Lopez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4205-0754","authenticated-orcid":false,"given":"Weizhou","family":"Yue","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5300-8151","authenticated-orcid":false,"given":"Annalise","family":"Bond","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brianna M.","family":"Rivera","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Miranda C.","family":"Sullivan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masakazu","family":"Hirouchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kurt","family":"Giles","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Atsushi","family":"Aoyagi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8454-5360","authenticated-orcid":false,"given":"Carlo","family":"Condello","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,1,9]]},"reference":[{"key":"35753_CR1","doi-asserted-by":"publisher","DOI":"10.1186\/s12974-019-1453-0","volume":"16","author":"DA Dionisio-Santos","year":"2019","unstructured":"Dionisio-Santos, D. A., Olschowka, J. A. & O\u2019Banion, M. K. Exploiting microglial and peripheral immune cell crosstalk to treat Alzheimer\u2019s disease. J. Neuroinflammation 16, 74 (2019).","journal-title":"J. Neuroinflammation"},{"key":"35753_CR2","doi-asserted-by":"publisher","first-page":"388","DOI":"10.1038\/s41586-019-0924-x","volume":"566","author":"T Masuda","year":"2019","unstructured":"Masuda, T. et al. Spatial and temporal heterogeneity of mouse and human microglia at single-cell resolution. Nature 566, 388\u2013392 (2019).","journal-title":"Nature"},{"key":"35753_CR3","doi-asserted-by":"publisher","first-page":"741","DOI":"10.1016\/j.molmed.2019.05.001","volume":"25","author":"L Kodama","year":"2019","unstructured":"Kodama, L. & Gan, L. Do microglial sex differences contribute to sex differences in neurodegenerative diseases? Trends Mol. Med. 25, 741\u2013749 (2019).","journal-title":"Trends Mol. Med."},{"key":"35753_CR4","doi-asserted-by":"publisher","first-page":"e101997","DOI":"10.15252\/embj.2019101997","volume":"38","author":"V Stratoulias","year":"2019","unstructured":"Stratoulias, V., Venero, J. L., Tremblay, M. E. & Joseph, B. Microglial subtypes: diversity within the microglial community. EMBO J. 38, e101997 (2019).","journal-title":"EMBO J."},{"key":"35753_CR5","doi-asserted-by":"publisher","first-page":"104962","DOI":"10.1016\/j.nbd.2020.104962","volume":"143","author":"T Schwabe","year":"2020","unstructured":"Schwabe, T., Srinivasan, K. & Rhinn, H. Shifting paradigms: The central role of microglia in Alzheimer\u2019s disease. Neurobiol. Dis. 143, 104962 (2020).","journal-title":"Neurobiol. Dis."},{"key":"35753_CR6","doi-asserted-by":"publisher","first-page":"759","DOI":"10.1038\/s41577-018-0051-1","volume":"18","author":"Y Shi","year":"2018","unstructured":"Shi, Y. & Holtzman, D. M. Interplay between innate immunity and Alzheimer disease: APOE and TREM2 in the spotlight. Nat. Rev. Immunol. 18, 759\u2013772 (2018).","journal-title":"Nat. Rev. Immunol."},{"key":"35753_CR7","doi-asserted-by":"publisher","first-page":"1738","DOI":"10.1093\/brain\/awv081","volume":"138","author":"N Maphis","year":"2015","unstructured":"Maphis, N. et al. Reactive microglia drive tau pathology and contribute to the spreading of pathological tau in the brain. Brain 138, 1738\u20131755 (2015).","journal-title":"Brain"},{"key":"35753_CR8","doi-asserted-by":"publisher","first-page":"599","DOI":"10.1007\/s00401-018-01957-y","volume":"137","author":"IC Stancu","year":"2019","unstructured":"Stancu, I. C. et al. Aggregated Tau activates NLRP3-ASC inflammasome exacerbating exogenously seeded and non-exogenously seeded Tau pathology in vivo. Acta Neuropathol. 137, 599\u2013617 (2019).","journal-title":"Acta Neuropathol."},{"key":"35753_CR9","doi-asserted-by":"publisher","first-page":"669","DOI":"10.1038\/s41586-019-1769-z","volume":"575","author":"C Ising","year":"2019","unstructured":"Ising, C. et al. NLRP3 inflammasome activation drives tau pathology. Nature 575, 669\u2013673 (2019).","journal-title":"Nature"},{"key":"35753_CR10","doi-asserted-by":"publisher","first-page":"108398","DOI":"10.1016\/j.celrep.2020.108398","volume":"33","author":"JE Rexach","year":"2020","unstructured":"Rexach, J. E. et al. Tau pathology drives dementia risk-associated gene networks toward chronic inflammatory states and immunosuppression. Cell Rep. 33, 108398 (2020).","journal-title":"Cell Rep."},{"key":"35753_CR11","doi-asserted-by":"publisher","first-page":"709","DOI":"10.1007\/s00401-018-1900-5","volume":"136","author":"M Allen","year":"2018","unstructured":"Allen, M. et al. Divergent brain gene expression patterns associate with distinct cell-specific tau neuropathology traits in progressive supranuclear palsy. Acta Neuropathol. 136, 709\u2013727 (2018).","journal-title":"Acta Neuropathol."},{"key":"35753_CR12","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1186\/s13024-018-0296-y","volume":"13","author":"H Wang","year":"2018","unstructured":"Wang, H. et al. Genome-wide RNAseq study of the molecular mechanisms underlying microglia activation in response to pathological tau perturbation in the rTg4510 tau transgenic animal model. Mol. Neurodegener. 13, 65 (2018).","journal-title":"Mol. Neurodegener."},{"key":"35753_CR13","doi-asserted-by":"publisher","first-page":"633","DOI":"10.1016\/j.celrep.2014.12.041","volume":"10","author":"M Matarin","year":"2015","unstructured":"Matarin, M. et al. A genome-wide gene-expression analysis and database in transgenic mice during development of amyloid or tau pathology. Cell Rep. 10, 633\u2013644 (2015).","journal-title":"Cell Rep."},{"key":"35753_CR14","doi-asserted-by":"crossref","unstructured":"Stanley, E. R. & Chitu, V. CSF-1 receptor signaling in myeloid cells. Cold Spring Harb. Perspect Biol. 6 (2014).","DOI":"10.1101\/cshperspect.a021857"},{"key":"35753_CR15","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1186\/s40425-017-0257-y","volume":"5","author":"MA Cannarile","year":"2017","unstructured":"Cannarile, M. A. et al. Colony-stimulating factor 1 receptor (CSF1R) inhibitors in cancer therapy. J. Immunother. Cancer 5, 53 (2017).","journal-title":"J. Immunother. Cancer"},{"key":"35753_CR16","doi-asserted-by":"publisher","first-page":"1584","DOI":"10.1038\/nn.4132","volume":"18","author":"H Asai","year":"2015","unstructured":"Asai, H. et al. Depletion of microglia and inhibition of exosome synthesis halt tau propagation. Nat. Neurosci. 18, 1584\u20131593 (2015).","journal-title":"Nat. Neurosci."},{"key":"35753_CR17","doi-asserted-by":"publisher","first-page":"2546","DOI":"10.1084\/jem.20190980","volume":"216","author":"Y Shi","year":"2019","unstructured":"Shi, Y. et al. Microglia drive APOE-dependent neurodegeneration in a tauopathy mouse model. J. Exp. Med. 216, 2546\u20132561 (2019).","journal-title":"J. Exp. Med."},{"key":"35753_CR18","doi-asserted-by":"publisher","first-page":"3243","DOI":"10.1093\/brain\/awz241","volume":"142","author":"R Mancuso","year":"2019","unstructured":"Mancuso, R. et al. CSF1R inhibitor JNJ-40346527 attenuates microglial proliferation and neurodegeneration in P301S mice. Brain 142, 3243\u20133264 (2019).","journal-title":"Brain"},{"key":"35753_CR19","doi-asserted-by":"publisher","DOI":"10.1186\/s12974-018-1348-5","volume":"15","author":"RE Bennett","year":"2018","unstructured":"Bennett, R. E. et al. Partial reduction of microglia does not affect tau pathology in aged mice. J. Neuroinflammation 15, 311 (2018).","journal-title":"J. Neuroinflammation"},{"key":"35753_CR20","doi-asserted-by":"publisher","first-page":"802","DOI":"10.1016\/S1474-4422(20)30274-X","volume":"19","author":"C Condello","year":"2020","unstructured":"Condello, C., DeGrado, W. F. & Prusiner, S. B. Prion biology: implications for Alzheimer\u2019s disease therapeutics. Lancet Neurol. 19, 802\u2013803 (2020).","journal-title":"Lancet Neurol."},{"key":"35753_CR21","doi-asserted-by":"publisher","first-page":"428","DOI":"10.1056\/NEJMoa1411366","volume":"373","author":"WD Tap","year":"2015","unstructured":"Tap, W. D. et al. Structure-guided blockade of CSF1R kinase in tenosynovial giant-cell tumor. N. Engl. J. Med. 373, 428\u2013437 (2015).","journal-title":"N. Engl. J. Med."},{"key":"35753_CR22","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-019-11674-z","volume":"10","author":"E Spangenberg","year":"2019","unstructured":"Spangenberg, E. et al. Sustained microglial depletion with CSF1R inhibitor impairs parenchymal plaque development in an Alzheimer\u2019s disease model. Nat. Commun. 10, 3758 (2019).","journal-title":"Nat. Commun."},{"key":"35753_CR23","doi-asserted-by":"publisher","first-page":"9340","DOI":"10.1523\/JNEUROSCI.22-21-09340.2002","volume":"22","author":"B Allen","year":"2002","unstructured":"Allen, B. et al. Abundant tau filaments and nonapoptotic neurodegeneration in transgenic mice expressing human P301S tau protein. J. Neurosci. 22, 9340\u20139351 (2002).","journal-title":"J. Neurosci."},{"key":"35753_CR24","doi-asserted-by":"publisher","first-page":"667","DOI":"10.1097\/00005072-199906000-00011","volume":"58","author":"O Bugiani","year":"1999","unstructured":"Bugiani, O. et al. Frontotemporal dementia and corticobasal degeneration in a family with a P301S mutation in tau. J. Neuropathol. Exp. Neurol. 58, 667\u2013677 (1999).","journal-title":"J. Neuropathol. Exp. Neurol."},{"key":"35753_CR25","doi-asserted-by":"publisher","first-page":"306","DOI":"10.1016\/S0014-5793(99)00508-6","volume":"450","author":"M Goedert","year":"1999","unstructured":"Goedert, M., Jakes, R. & Crowther, R. A. Effects of frontotemporal dementia FTDP-17 mutations on heparin-induced assembly of tau filaments. FEBS Lett. 450, 306\u2013311 (1999).","journal-title":"FEBS Lett."},{"key":"35753_CR26","doi-asserted-by":"publisher","first-page":"708","DOI":"10.1002\/1531-8249(199911)46:5<708::AID-ANA5>3.0.CO;2-K","volume":"46","author":"AD Sperfeld","year":"1999","unstructured":"Sperfeld, A. D. et al. FTDP-17: an early-onset phenotype with parkinsonism and epileptic seizures caused by a novel mutation. Ann. Neurol. 46, 708\u2013715 (1999).","journal-title":"Ann. Neurol."},{"key":"35753_CR27","doi-asserted-by":"publisher","first-page":"E11029","DOI":"10.1073\/pnas.1717193114","volume":"114","author":"NR Johnson","year":"2017","unstructured":"Johnson, N. R. et al. Evidence for sortilin modulating regional accumulation of human tau prions in transgenic mice. Proc. Natl Acad. Sci. USA 114, E11029\u2013E11036 (2017).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"35753_CR28","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1007\/s00401-020-02158-2","volume":"140","author":"GG Kovacs","year":"2020","unstructured":"Kovacs, G. G. et al. Distribution patterns of tau pathology in progressive supranuclear palsy. Acta Neuropathol. 140, 99\u2013119 (2020).","journal-title":"Acta Neuropathol."},{"key":"35753_CR29","doi-asserted-by":"publisher","first-page":"1271","DOI":"10.1016\/j.neuron.2014.04.047","volume":"82","author":"DW Sanders","year":"2014","unstructured":"Sanders, D. W. et al. Distinct tau prion strains propagate in cells and mice and define different tauopathies. Neuron 82, 1271\u20131288 (2014).","journal-title":"Neuron"},{"key":"35753_CR30","doi-asserted-by":"crossref","unstructured":"Aoyagi, A. et al. Abeta and tau prion-like activities decline with longevity in the Alzheimer\u2019s disease human brain. Sci. Transl. Med. 11 (2019).","DOI":"10.1126\/scitranslmed.aat8462"},{"key":"35753_CR31","doi-asserted-by":"publisher","first-page":"e0122912","DOI":"10.1371\/journal.pone.0122912","volume":"10","author":"MR Elmore","year":"2015","unstructured":"Elmore, M. R., Lee, R. J., West, B. L. & Green, K. N. Characterizing newly repopulated microglia in the adult mouse: impacts on animal behavior, cell morphology, and neuroinflammation. PLoS One 10, e0122912 (2015).","journal-title":"PLoS One"},{"key":"35753_CR32","doi-asserted-by":"publisher","first-page":"1024","DOI":"10.1523\/JNEUROSCI.2642-12.2013","volume":"33","author":"M Iba","year":"2013","unstructured":"Iba, M. et al. Synthetic tau fibrils mediate transmission of neurofibrillary tangles in a transgenic mouse model of Alzheimer\u2019s-like tauopathy. J. Neurosci. 33, 1024\u20131037 (2013).","journal-title":"J. Neurosci."},{"key":"35753_CR33","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1016\/j.neuron.2009.03.024","volume":"62","author":"WW Seeley","year":"2009","unstructured":"Seeley, W. W., Crawford, R. K., Zhou, J., Miller, B. L. & Greicius, M. D. Neurodegenerative diseases target large-scale human brain networks. Neuron 62, 42\u201352 (2009).","journal-title":"Neuron"},{"key":"35753_CR34","doi-asserted-by":"publisher","first-page":"9511","DOI":"10.1021\/bi00198a017","volume":"33","author":"N Gustke","year":"1994","unstructured":"Gustke, N., Trinczek, B., Biernat, J., Mandelkow, E. M. & Mandelkow, E. Domains of tau protein and interactions with microtubules. Biochemistry 33, 9511\u20139522 (1994).","journal-title":"Biochemistry"},{"key":"35753_CR35","doi-asserted-by":"publisher","first-page":"23336","DOI":"10.1073\/pnas.1922788117","volume":"117","author":"F Lei","year":"2020","unstructured":"Lei, F. et al. CSF1R inhibition by a small-molecule inhibitor is not microglia specific; affecting hematopoiesis and the function of macrophages. Proc. Natl Acad. Sci. USA 117, 23336\u201323338 (2020).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"35753_CR36","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-019-08446-0","volume":"10","author":"V Bellver-Landete","year":"2019","unstructured":"Bellver-Landete, V. et al. Microglia are an essential component of the neuroprotective scar that forms after spinal cord injury. Nat. Commun. 10, 518 (2019).","journal-title":"Nat. Commun."},{"key":"35753_CR37","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1084\/jem.20120412","volume":"210","author":"J Luo","year":"2013","unstructured":"Luo, J. et al. Colony-stimulating factor 1 receptor (CSF1R) signaling in injured neurons facilitates protection and survival. J. Exp. Med. 210, 157\u2013172 (2013).","journal-title":"J. Exp. Med."},{"key":"35753_CR38","doi-asserted-by":"publisher","first-page":"783","DOI":"10.3233\/JAD-150292","volume":"49","author":"P Jul","year":"2016","unstructured":"Jul, P. et al. Hyperactivity with agitative-like behavior in a mouse tauopathy model. J. Alzheimers Dis. 49, 783\u2013795 (2016).","journal-title":"J. Alzheimers Dis."},{"key":"35753_CR39","doi-asserted-by":"publisher","first-page":"4063","DOI":"10.1096\/fj.11-186650","volume":"25","author":"M Dumont","year":"2011","unstructured":"Dumont, M. et al. Behavioral deficit, oxidative stress, and mitochondrial dysfunction precede tau pathology in P301S transgenic mice. FASEB J. 25, 4063\u20134072 (2011).","journal-title":"FASEB J."},{"key":"35753_CR40","doi-asserted-by":"publisher","first-page":"e0195486","DOI":"10.1371\/journal.pone.0195486","volume":"13","author":"X Wang","year":"2018","unstructured":"Wang, X. et al. Early intervention of tau pathology prevents behavioral changes in the rTg4510 mouse model of tauopathy. PLoS One 13, e0195486 (2018).","journal-title":"PLoS One"},{"key":"35753_CR41","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1016\/j.neuron.2016.05.018","volume":"91","author":"M Bacioglu","year":"2016","unstructured":"Bacioglu, M. et al. Neurofilament light chain in blood and CSF as marker of disease progression in mouse models and in neurodegenerative diseases. Neuron 91, 56\u201366 (2016).","journal-title":"Neuron"},{"key":"35753_CR42","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1186\/s40478-018-0649-3","volume":"7","author":"NJ Ashton","year":"2019","unstructured":"Ashton, N. J. et al. Increased plasma neurofilament light chain concentration correlates with severity of post-mortem neurofibrillary tangle pathology and neurodegeneration. Acta Neuropathol. Commun. 7, 5 (2019).","journal-title":"Acta Neuropathol. Commun."},{"key":"35753_CR43","doi-asserted-by":"publisher","first-page":"e273","DOI":"10.1212\/WNL.0000000000004859","volume":"90","author":"JC Rojas","year":"2018","unstructured":"Rojas, J. C. et al. CSF neurofilament light chain and phosphorylated tau 181 predict disease progression in PSP. Neurology 90, e273\u2013e281 (2018).","journal-title":"Neurology"},{"key":"35753_CR44","doi-asserted-by":"publisher","first-page":"1693","DOI":"10.2147\/DDDT.S253232","volume":"14","author":"B Benner","year":"2020","unstructured":"Benner, B. et al. Pexidartinib, a novel small molecule CSF-1R inhibitor in use for tenosynovial giant cell tumor: a systematic review of pre-clinical and clinical development. Drug Des. Devel Ther. 14, 1693\u20131704 (2020).","journal-title":"Drug Des. Devel Ther."},{"key":"35753_CR45","doi-asserted-by":"publisher","first-page":"379","DOI":"10.1038\/aps.2009.24","volume":"30","author":"XX Dong","year":"2009","unstructured":"Dong, X. X., Wang, Y. & Qin, Z. H. Molecular mechanisms of excitotoxicity and their relevance to pathogenesis of neurodegenerative diseases. Acta Pharm. Sin. 30, 379\u2013387 (2009).","journal-title":"Acta Pharm. Sin."},{"key":"35753_CR46","doi-asserted-by":"publisher","first-page":"481","DOI":"10.1038\/nature21029","volume":"541","author":"SA Liddelow","year":"2017","unstructured":"Liddelow, S. A. et al. Neurotoxic reactive astrocytes are induced by activated microglia. Nature 541, 481\u2013487 (2017).","journal-title":"Nature"},{"key":"35753_CR47","doi-asserted-by":"publisher","first-page":"2528","DOI":"10.1073\/pnas.1019034108","volume":"108","author":"JC Watts","year":"2011","unstructured":"Watts, J. C. et al. Bioluminescence imaging of Abeta deposition in bigenic mouse models of Alzheimer\u2019s disease. Proc. Natl Acad. Sci. USA 108, 2528\u20132533 (2011).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"35753_CR48","doi-asserted-by":"publisher","first-page":"1643","DOI":"10.1016\/S0002-9440(10)63421-9","volume":"165","author":"A Bellucci","year":"2004","unstructured":"Bellucci, A. et al. Induction of inflammatory mediators and microglial activation in mice transgenic for mutant human P301S tau protein. Am. J. Pathol. 165, 1643\u20131652 (2004).","journal-title":"Am. J. Pathol."},{"key":"35753_CR49","doi-asserted-by":"publisher","first-page":"647","DOI":"10.1093\/jnen\/60.6.647","volume":"60","author":"K Ishizawa","year":"2001","unstructured":"Ishizawa, K. & Dickson, D. W. Microglial activation parallels system degeneration in progressive supranuclear palsy and corticobasal degeneration. J. Neuropathol. Exp. Neurol. 60, 647\u2013657 (2001).","journal-title":"J. Neuropathol. Exp. Neurol."},{"key":"35753_CR50","doi-asserted-by":"publisher","first-page":"832","DOI":"10.1016\/j.celrep.2017.12.066","volume":"22","author":"BA Friedman","year":"2018","unstructured":"Friedman, B. A. et al. Diverse brain myeloid expression profiles reveal distinct microglial activation states and aspects of Alzheimer\u2019s disease not evident in mouse models. Cell Rep. 22, 832\u2013847 (2018).","journal-title":"Cell Rep."},{"key":"35753_CR51","doi-asserted-by":"publisher","first-page":"1276","DOI":"10.1016\/j.cell.2017.05.018","volume":"169","author":"H Keren-Shaul","year":"2017","unstructured":"Keren-Shaul, H. et al. A unique microglia type associated with restricting development of Alzheimer\u2019s Disease. Cell 169, 1276\u20131290 e1217 (2017).","journal-title":"Cell"},{"key":"35753_CR52","doi-asserted-by":"publisher","first-page":"876","DOI":"10.1126\/science.1184819","volume":"328","author":"PJ Mucha","year":"2010","unstructured":"Mucha, P. J., Richardson, T., Macon, K., Porter, M. A. & Onnela, J. P. Community structure in time-dependent, multiscale, and multiplex networks. Science 328, 876\u2013878 (2010).","journal-title":"Science"},{"key":"35753_CR53","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-022-29552-6","volume":"13","author":"C Wang","year":"2022","unstructured":"Wang, C. et al. Microglial NF-kappaB drives tau spreading and toxicity in a mouse model of tauopathy. Nat. Commun. 13, 1969 (2022).","journal-title":"Nat. Commun."},{"key":"35753_CR54","doi-asserted-by":"publisher","first-page":"39447","DOI":"10.1074\/jbc.M110.132522","volume":"285","author":"J Hong","year":"2010","unstructured":"Hong, J. et al. Microglial Toll-like receptor 2 contributes to kainic acid-induced glial activation and hippocampal neuronal cell death. J. Biol. Chem. 285, 39447\u201339457 (2010).","journal-title":"J. Biol. Chem."},{"key":"35753_CR55","doi-asserted-by":"publisher","first-page":"674","DOI":"10.1038\/nature11729","volume":"493","author":"MT Heneka","year":"2013","unstructured":"Heneka, M. T. et al. NLRP3 is activated in Alzheimer\u2019s disease and contributes to pathology in APP\/PS1 mice. Nature 493, 674\u2013678 (2013).","journal-title":"Nature"},{"key":"35753_CR56","doi-asserted-by":"publisher","first-page":"566","DOI":"10.1016\/j.immuni.2017.08.008","volume":"47","author":"S Krasemann","year":"2017","unstructured":"Krasemann, S. et al. The TREM2-APOE pathway drives the transcriptional phenotype of dysfunctional microglia in neurodegenerative diseases. Immunity 47, 566\u2013581 e569 (2017).","journal-title":"Immunity"},{"key":"35753_CR57","doi-asserted-by":"publisher","first-page":"1322","DOI":"10.1016\/j.neuron.2018.10.014","volume":"100","author":"B Dejanovic","year":"2018","unstructured":"Dejanovic, B. et al. Changes in the synaptic proteome in tauopathy and rescue of tau-induced synapse loss by C1q antibodies. Neuron 100, 1322\u20131336 e1327 (2018).","journal-title":"Neuron"},{"key":"35753_CR58","doi-asserted-by":"publisher","first-page":"931","DOI":"10.1038\/s41591-018-0051-5","volume":"24","author":"SP Yun","year":"2018","unstructured":"Yun, S. P. et al. Block of A1 astrocyte conversion by microglia is neuroprotective in models of Parkinson\u2019s disease. Nat. Med. 24, 931\u2013938 (2018).","journal-title":"Nat. Med."},{"key":"35753_CR59","doi-asserted-by":"publisher","first-page":"9512","DOI":"10.7150\/thno.44394","volume":"10","author":"D Kerkhofs","year":"2020","unstructured":"Kerkhofs, D. et al. Pharmacological depletion of microglia and perivascular macrophages prevents Vascular Cognitive Impairment in Ang II-induced hypertension. Theranostics 10, 9512\u20139527 (2020).","journal-title":"Theranostics"},{"key":"35753_CR60","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1016\/j.expneurol.2019.04.011","volume":"318","author":"Y Liu","year":"2019","unstructured":"Liu, Y. et al. Concentration-dependent effects of CSF1R inhibitors on oligodendrocyte progenitor cells ex vivo and in vivo. Exp. Neurol. 318, 32\u201341 (2019).","journal-title":"Exp. Neurol."},{"key":"35753_CR61","doi-asserted-by":"crossref","unstructured":"Zhan, L. et al. A MAC2-positive progenitor-like microglial population is resistant to CSF1R inhibition in adult mouse brain. Elife 9 (2020).","DOI":"10.7554\/eLife.51796"},{"key":"35753_CR62","doi-asserted-by":"publisher","first-page":"1265","DOI":"10.1093\/brain\/aww016","volume":"139","author":"EE Spangenberg","year":"2016","unstructured":"Spangenberg, E. E. et al. Eliminating microglia in Alzheimer\u2019s mice prevents neuronal loss without modulating amyloid-beta pathology. Brain 139, 1265\u20131281 (2016).","journal-title":"Brain"},{"key":"35753_CR63","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1038\/s41593-019-0560-7","volume":"23","author":"L Kodama","year":"2020","unstructured":"Kodama, L. et al. Microglial microRNAs mediate sex-specific responses to tau pathology. Nat. Neurosci. 23, 167\u2013171 (2020).","journal-title":"Nat. Neurosci."},{"key":"35753_CR64","doi-asserted-by":"publisher","first-page":"2773","DOI":"10.1016\/j.celrep.2018.08.001","volume":"24","author":"D Guneykaya","year":"2018","unstructured":"Guneykaya, D. et al. Transcriptional and translational differences of microglia from male and female brains. Cell Rep. 24, 2773\u20132783 e2776 (2018).","journal-title":"Cell Rep."},{"key":"35753_CR65","doi-asserted-by":"publisher","first-page":"2235","DOI":"10.1084\/jem.20180653","volume":"215","author":"SS Kang","year":"2018","unstructured":"Kang, S. S. et al. Microglial translational profiling reveals a convergent APOE pathway from aging, amyloid, and tau. J. Exp. Med. 215, 2235\u20132245 (2018).","journal-title":"J. Exp. Med."},{"key":"35753_CR66","doi-asserted-by":"publisher","first-page":"1379","DOI":"10.1038\/s41593-022-01167-6","volume":"25","author":"G Colombo","year":"2022","unstructured":"Colombo, G. et al. A tool for mapping microglial morphology, morphOMICs, reveals brain-region and sex-dependent phenotypes. Nat. Neurosci. 25, 1379\u20131393 (2022).","journal-title":"Nat. Neurosci."},{"key":"35753_CR67","doi-asserted-by":"publisher","first-page":"9973","DOI":"10.1523\/JNEUROSCI.0834-10.2010","volume":"30","author":"DW Hampton","year":"2010","unstructured":"Hampton, D. W. et al. Cell-mediated neuroprotection in a mouse model of human tauopathy. J. Neurosci. 30, 9973\u20139983 (2010).","journal-title":"J. Neurosci."},{"key":"35753_CR68","doi-asserted-by":"publisher","DOI":"10.1186\/s12974-020-01996-x","volume":"17","author":"K Berve","year":"2020","unstructured":"Berve, K., West, B. L., Martini, R. & Groh, J. Sex- and region-biased depletion of microglia\/macrophages attenuates CLN1 disease in mice. J. Neuroinflammation 17, 323 (2020).","journal-title":"J. Neuroinflammation"},{"key":"35753_CR69","doi-asserted-by":"publisher","DOI":"10.1186\/1742-2094-9-27","volume":"9","author":"J Vinet","year":"2012","unstructured":"Vinet, J. et al. Neuroprotective function for ramified microglia in hippocampal excitotoxicity. J. Neuroinflammation 9, 27 (2012).","journal-title":"J. Neuroinflammation"},{"key":"35753_CR70","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1038\/s41593-018-0289-8","volume":"22","author":"MA Busche","year":"2019","unstructured":"Busche, M. A. et al. Tau impairs neural circuits, dominating amyloid-beta effects, in Alzheimer models in vivo. Nat. Neurosci. 22, 57\u201364 (2019).","journal-title":"Nat. Neurosci."},{"key":"35753_CR71","doi-asserted-by":"publisher","first-page":"417","DOI":"10.1038\/s41586-020-2777-8","volume":"586","author":"A Badimon","year":"2020","unstructured":"Badimon, A. et al. Negative feedback control of neuronal activity by microglia. Nature 586, 417\u2013423 (2020).","journal-title":"Nature"},{"key":"35753_CR72","doi-asserted-by":"publisher","first-page":"C605","DOI":"10.1152\/ajpcell.00205.2020","volume":"319","author":"M Liu","year":"2020","unstructured":"Liu, M. et al. Microglia depletion exacerbates acute seizures and hippocampal neuronal degeneration in mouse models of epilepsy. Am. J. Physiol. Cell Physiol. 319, C605\u2013C610 (2020).","journal-title":"Am. J. Physiol. Cell Physiol."},{"key":"35753_CR73","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1186\/s13024-018-0244-x","volume":"13","author":"J Sosna","year":"2018","unstructured":"Sosna, J. et al. Early long-term administration of the CSF1R inhibitor PLX3397 ablates microglia and reduces accumulation of intraneuronal amyloid, neuritic plaque deposition and pre-fibrillar oligomers in 5XFAD mouse model of Alzheimer\u2019s disease. Mol. Neurodegener. 13, 11 (2018).","journal-title":"Mol. Neurodegener."},{"key":"35753_CR74","doi-asserted-by":"publisher","first-page":"887","DOI":"10.1016\/j.neuron.2020.09.010","volume":"108","author":"B Pinto","year":"2020","unstructured":"Pinto, B. et al. Rescuing over-activated microglia restores cognitive performance in Juvenile animals of the Dp(16) mouse model of down syndrome. Neuron 108, 887\u2013904 e812 (2020).","journal-title":"Neuron"},{"key":"35753_CR75","doi-asserted-by":"publisher","DOI":"10.1186\/s12974-015-0366-9","volume":"12","author":"NN Dagher","year":"2015","unstructured":"Dagher, N. N. et al. Colony-stimulating factor 1 receptor inhibition prevents microglial plaque association and improves cognition in 3xTg-AD mice. J. Neuroinflammation 12, 139 (2015).","journal-title":"J. Neuroinflammation"},{"key":"35753_CR76","doi-asserted-by":"publisher","DOI":"10.1186\/s13550-017-0305-0","volume":"7","author":"AT Hillmer","year":"2017","unstructured":"Hillmer, A. T. et al. Microglial depletion and activation: A [(11)C]PBR28 PET study in nonhuman primates. EJNMMI Res. 7, 59 (2017).","journal-title":"EJNMMI Res."},{"key":"35753_CR77","doi-asserted-by":"publisher","first-page":"779","DOI":"10.1016\/j.celrep.2017.07.004","volume":"20","author":"P Reu","year":"2017","unstructured":"Reu, P. et al. The lifespan and turnover of microglia in the human brain. Cell Rep. 20, 779\u2013784 (2017).","journal-title":"Cell Rep."},{"key":"35753_CR78","doi-asserted-by":"publisher","first-page":"1686","DOI":"10.1073\/pnas.1812155116","volume":"116","author":"AG Horti","year":"2019","unstructured":"Horti, A. G. et al. PET imaging of microglia by targeting macrophage colony-stimulating factor 1 receptor (CSF1R). Proc. Natl Acad. Sci. USA 116, 1686\u20131691 (2019).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"35753_CR79","doi-asserted-by":"publisher","first-page":"1690","DOI":"10.1016\/j.celrep.2016.06.099","volume":"16","author":"SH Lee","year":"2016","unstructured":"Lee, S. H. et al. Antibody-mediated targeting of tau in vivo does not require effector function and microglial engagement. Cell Rep. 16, 1690\u20131700 (2016).","journal-title":"Cell Rep."},{"key":"35753_CR80","doi-asserted-by":"publisher","first-page":"380","DOI":"10.1016\/j.neuron.2014.02.040","volume":"82","author":"MR Elmore","year":"2014","unstructured":"Elmore, M. R. et al. Colony-stimulating factor 1 receptor signaling is necessary for microglia viability, unmasking a microglia progenitor cell in the adult brain. Neuron 82, 380\u2013397 (2014).","journal-title":"Neuron"},{"key":"35753_CR81","first-page":"35","volume":"299","author":"S Barghorn","year":"2005","unstructured":"Barghorn, S., Biernat, J. & Mandelkow, E. Purification of recombinant tau protein and preparation of Alzheimer-paired helical filaments in vitro. Methods Mol. Biol. 299, 35\u201351 (2005).","journal-title":"Methods Mol. Biol."},{"key":"35753_CR82","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1016\/j.neuron.2015.11.013","volume":"89","author":"Y Zhang","year":"2016","unstructured":"Zhang, Y. et al. Purification and characterization of progenitor and mature human astrocytes reveals transcriptional and functional differences with mouse. Neuron 89, 37\u201353 (2016).","journal-title":"Neuron"},{"key":"35753_CR83","doi-asserted-by":"publisher","first-page":"313","DOI":"10.1016\/j.neuron.2017.09.026","volume":"96","author":"YE Wu","year":"2017","unstructured":"Wu, Y. E., Pan, L., Zuo, Y., Li, X. & Hong, W. Detecting activated cell populations using single-cell RNA-seq. Neuron 96, 313\u2013329 e316 (2017).","journal-title":"Neuron"},{"key":"35753_CR84","doi-asserted-by":"publisher","first-page":"385","DOI":"10.1016\/j.celrep.2013.06.018","volume":"4","author":"IM Chiu","year":"2013","unstructured":"Chiu, I. M. et al. A neurodegeneration-specific gene-expression signature of acutely isolated microglia from an amyotrophic lateral sclerosis mouse model. Cell Rep. 4, 385\u2013401 (2013).","journal-title":"Cell Rep."},{"key":"35753_CR85","doi-asserted-by":"publisher","first-page":"523","DOI":"10.1038\/nmeth.3393","volume":"12","author":"H Tsugawa","year":"2015","unstructured":"Tsugawa, H. et al. MS-DIAL: data-independent MS\/MS deconvolution for comprehensive metabolome analysis. Nat. Methods 12, 523\u2013526 (2015).","journal-title":"Nat. Methods"}],"container-title":["Nature Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41467-022-35753-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-022-35753-w","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-022-35753-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,1,13]],"date-time":"2023-01-13T10:14:10Z","timestamp":1673604850000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41467-022-35753-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,1,9]]},"references-count":85,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2023,12]]}},"alternative-id":["35753"],"URL":"https:\/\/doi.org\/10.1038\/s41467-022-35753-w","relation":{},"ISSN":["2041-1723"],"issn-type":[{"value":"2041-1723","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,1,9]]},"assertion":[{"value":"21 March 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 December 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 January 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The Institute for Neurodegenerative Diseases (UCSF) had a research collaboration with Daiichi Sankyo, Inc. (Tokyo, Japan). All other authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"118"}}